MiR-99a-5p Constrains Epithelial-Mesenchymal Transition of Cervical Squamous Cell Carcinoma Via Targeting CDC25A/IL6
- PMID: 35532870
- DOI: 10.1007/s12033-022-00496-y
MiR-99a-5p Constrains Epithelial-Mesenchymal Transition of Cervical Squamous Cell Carcinoma Via Targeting CDC25A/IL6
Abstract
MiR-99a-5p participates in processes and pathogenesis of varying diseases. However, the molecular mechanism of miR-99a-5p in human cervical squamous cell carcinoma (CSCC) remains unclear. Here, we found that miR-99a-5p was lowly expressed in CSCC cells and negatively associated with overall survival. In addition, cellular experiments including CCK8, wound healing, Transwell and flow cytometry assays disclosed that transfection of miR-99a-5p mimic could suppress the cell activity, cell migratory, and invasive abilities, and promote cell apoptosis, thus inhibiting the tumor progression of CSCC cells. Luciferase reporter gene assay indicated that miR-99a-5p targeted 3'-UTR of CDC25A. Also, enforced CDC25A level rescued the impact of miR-99a-5p on CSCC progression. Silencing CDC25A could restrain the mRNA and protein levels of IL-6 in CSCC. CDC25A overexpression or IL-6 treatment could attenuate inhibiting impact of miR-99a-5p overexpression on epithelial-mesenchymal transition (EMT). These findings suggested that miR-99a-5p may play an anti-tumor role in tumor metastasis by targeting CDC25A/IL6 to hamper EMT process, which revealed a novel molecular mechanism in CSCC.
Keywords: Apoptosis; IL-6; Invasion; Migration; miR-99a-5p; cervical squamous cell carcinoma (CSCC); CDC25A.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- Cancer Genome Atlas Research, et al. (2017). Integrated genomic and molecular characterization of cervical cancer. Nature, 543, 378–384. https://doi.org/10.1038/nature21386 - DOI
-
- Sung, H., et al. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71, 209–249. https://doi.org/10.3322/caac.21660 - DOI
-
- Waggoner, S. E. (2003). Cervical cancer. Lancet, 361, 2217–2225. https://doi.org/10.1016/S0140-6736(03)13778-6 - DOI
-
- Crosbie, E. J., Einstein, M. H., Franceschi, S., & Kitchener, H. C. (2013). Human papillomavirus and cervical cancer. Lancet, 382, 889–899. https://doi.org/10.1016/S0140-6736(13)60022-7 - DOI
-
- Marth, C., et al. (2017). Cervical cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 28, 72–83. https://doi.org/10.1093/annonc/mdx220 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
